https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Measuring cognitive insight in people with problematic substance use: an exploration of the factor validity of the Beck Cognitive Insight Scale https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38082 2[22, n = 312] = 76.43, P ' 0.02). Internal consistency analyses indicated acceptable internal reliability (Self-Reflection a = 0.73, Self-Certainty a = 0.72, composite a = 0.75). Self-Certainty scores were significantly higher for participants with a self-reported psychotic disorder (M = 14.95 vs. M = 13.04, P = 0.007). Self-Reflection scores were higher for people experiencing psychological distress (M = 17.57 vs. M = 15.95, P = 0.001). Discussion and Conclusions: We found that a 12-item version of the BCIS had good psychometric properties in this substance-using population. Further research is needed to explore whether insight can predict treatment outcomes for substance use.]]> Tue 03 Aug 2021 18:14:35 AEST ]]> With a little help from my friends: cognitive-behavioral skill utilization, social networks, and psychological distress in SMART Recovery group attendees https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38071 Tue 03 Aug 2021 13:27:46 AEST ]]> Insight in substance use disorder: A systematic review of the literature https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41579 Thu 04 Apr 2024 11:48:07 AEDT ]]> Online SMART Recovery mutual support groups: Characteristics and experience of adults seeking treatment for methamphetamine compared to those seeking treatment for other addictive behaviours https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50642 Mon 31 Jul 2023 17:09:46 AEST ]]> Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38081 Mon 29 Apr 2024 13:46:22 AEST ]]> From both sides: participant and facilitator perceptions of SMART Recovery groups https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:32785 Mon 23 Jul 2018 15:51:16 AEST ]]> Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49563 0.05). After adjustment for demographic differences, participants who smoked had lower craving [b (SE) = −1.1 (0.5), P = 0.021] and were less likely to report psychotic symptoms [b (SE) = −1.8 (0.7), P = 0.013] or antidepressant use [b (SE) = −1.1 (0.5), P = 0.022]. Discussion and Conclusions: Smoking crystalline methamphetamine is associated with a younger less marginalised demographic profile than injecting methamphetamine, but a similarly severe clinical profile.]]> Mon 22 May 2023 09:20:09 AEST ]]>